Vogt-Koyanagi-Harada Syndrome Market Size & Share, by Type (Classic, Atypical), End User (Hospitals, Dermatology Clinics, Research Institutions) - Global Supply & Demand Analysis & Growth Forecasts, Statistics Report 2024-2036

  • Report ID: 5408
  • Published Date: Nov 28, 2023
  • Report Format: PDF, PPT

Companies Dominating the Vogt-Koyanagi-Harada Syndrome Landscape

top-features-companies
    • Genentech, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Regeneron Pharmaceuticals, Inc.
    • Novartis International AG
    • AbbVie Inc.
    • Johnson & Johnson
    • Roche Holding AG
    • Sanofi
    • Pfizer Inc.
    • Merck & Co., Inc.
    • Bristol-Myers Squibb Company

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Regeneron acquired Checkmate Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel immunotherapies for cancer, for USD 1.1 billion. The acquisition added several new immunotherapy candidates to Regeneron's pipeline, including CMP-001, a bispecific antibody that targets PD-1 and LAG-3, and CMP-002, a T cell engager that targets BCMA.
  • Regeneron acquired VXRT Inc., a clinical-stage biotechnology company developing vaccines and immunotherapies for infectious diseases and cancer, for USD 3.2 billion. The acquisition strengthened Regeneron's vaccine pipeline and added new vaccine candidates for COVID-19 and other infectious diseases.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 5408
  • Published Date: Nov 28, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing demand for healthcare sector is the major factor driving the market growth.

The market size of vogt-koyanagi-harada syndrome is anticipated to attain a CAGR of 8% over the forecast period, i.e., 2024-2036.

The major players in the market Genentech, Inc., Regeneron Pharmaceuticals, Inc., Novartis International AG, AbbVie Inc., Johnson & Johnson, Roche Holding AG, and others.

The hospitals segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the Asia Pacific region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying